about
A flexible computational framework for detecting, characterizing, and interpreting statistical patterns of epistasis in genetic studies of human disease susceptibilityAmiodarone Induces Overexpression of Similar to Versican b to Repress the EGFR/Gsk3b/Snail Signaling Axis during Cardiac Valve Formation of Zebrafish EmbryosNext-generation sequencing of nine atrial fibrillation candidate genes identified novel de novo mutations in patients with extreme trait of atrial fibrillation.A Novel Integrated Score Index of Echocardiographic Indices for the Evaluation of Left Ventricular Diastolic Function.Cardiac mechanics and ventricular twist by three-dimensional strain analysis in relation to B-type natriuretic peptide as a clinical prognosticator for heart failure patients.Statin use reduces the risk of dementia in elderly patients: a nationwide data survey and propensity analysis.Effects of angiotensin converting enzyme inhibition or angiotensin receptor blockade in dialysis patients: a nationwide data survey and propensity analysis.Cardiac myosin binding protein C and MAP-kinase activating death domain-containing gene polymorphisms and diastolic heart failure.Characteristics of Chinese patients with symptomatic Brugada syndrome in Taiwan.Distinct clinical features in the recipients of the implantable cardioverter defibrillator in Taiwan: a multicenter registry study.Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutationsDisease-targeted sequencing of ion channel genes identifies de novo mutations in patients with non-familial Brugada syndromeUnique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan.Thrombin induced connective tissue growth factor expression in rat vascular smooth muscle cells via the PAR-1/JNK/AP-1 pathway.Renin-angiotensin system gene polymorphisms and atrial fibrillation.Perfusion index derived from a pulse oximeter can detect changes in peripheral microcirculation during uretero-renal-scopy stone manipulation (URS-SM).Connective tissue growth factor and cardiac diastolic dysfunction: human data from the Taiwan diastolic heart failure registry and molecular basis by cellular and animal models.Left ventricular diastolic dysfunction in peritoneal dialysis: a forgotten risk factor.Galectin-3 level and the severity of cardiac diastolic dysfunction using cellular and animal models and clinical indices.Primary prevention of atrial fibrillation with beta-blockers in patients with end-stage renal disease undergoing dialysisDifferential baseline expression and angiotensin II-stimulation of leukemia-associated RhoGEF in vascular smooth muscle cells of spontaneously hypertensive ratsGenome-wide screening identifies a KCNIP1 copy number variant as a genetic predictor for atrial fibrillationRepolarization Alternans and Ventricular Arrhythmia in a Repaired Tetralogy of Fallot Animal Model.Utilizing multiple in silico analyses to identify putative causal SCN5A variants in Brugada syndrome.Angiotensin II regulates the LARG/RhoA/MYPT1 axis in rat vascular smooth muscle in vitro.Rimonabant inhibits TNF-α-induced endothelial IL-6 secretion via CB1 receptor and cAMP-dependent protein kinase pathway.Relation of Chlamydia pneumoniae infection in Taiwan to angiographically demonstrated coronary artery disease and to the presence of acute myocardial infarction or unstable angina pectoris.C-reactive protein gene polymorphism predicts the risk of thromboembolic stroke in patients with atrial fibrillation: a more than 10-year prospective follow-up study.TNF-α down-regulates sarcoplasmic reticulum Ca²⁺ ATPase expression and leads to left ventricular diastolic dysfunction through binding of NF-κB to promoter response element.2016 Guidelines of the Taiwan Heart Rhythm Society and the Taiwan Society of Cardiology for the management of atrial fibrillation.Renin-angiotensin system gene polymorphisms predict the risk of stroke in patients with atrial fibrillation: a 10-year prospective follow-up study.Additive effect of the metabolic syndrome score to the conventional CHADS₂ score for the thromboembolic risk stratification of patients with atrial fibrillation.Prognostic significance of left ventricular diastolic function in burn patients.Mechanical stretch of atrial myocyte monolayer decreases sarcoplasmic reticulum calcium adenosine triphosphatase expression and increases susceptibility to repolarization alternans.A functional variant in the promoter region regulates the C-reactive protein gene and is a potential candidate for increased risk of atrial fibrillation.The g.-762T>C polymorphism of the NPC1L1 gene is common in Chinese and contributes to a higher promoter activity and higher serum cholesterol levels.Renin-angiotensin system component expression in the HL-1 atrial cell line and in a pig model of atrial fibrillation.Functional polymorphisms of FGA, encoding alpha fibrinogen, are associated with susceptibility to venous thromboembolism in a Taiwanese population.Statin therapy lowers the risk of new-onset atrial fibrillation in patients with end-stage renal disease.Increased expression of mineralocorticoid receptor in human atrial fibrillation and a cellular model of atrial fibrillation.
P50
Q28295511-D282BB1E-48DD-406E-AD2B-E951AAB9B57CQ28551457-F2C4FACB-4A5B-4C8B-A548-FF5FAD77F083Q30368601-1B935E7E-F2B0-408B-9D85-5B6EA704EB0EQ30398867-02EA0198-3DEA-4459-81A1-25450F50A158Q30421429-77F5FB16-10CD-48DE-BC44-7595CA64F24AQ30809072-91384C0A-AB9A-49BC-8DBC-905A91105E9BQ30886019-0B895F67-5368-413D-A10D-DF12A4AEC5D4Q31058267-2B0DAD1C-580D-4941-AD52-1980BFDE9B06Q33149124-2E5A7DE7-1D67-4601-9DB9-8AFF1DE48866Q33150718-3497D432-A7B5-41FE-988B-DD5515C32788Q33157184-F4A2BFF1-D051-48B7-A747-D3D5B75B7CA5Q33164900-2485DF71-7637-4517-9F53-B1BD6DB12E53Q33165990-8B603E4E-A602-4397-97E0-5752A94961EAQ33566993-ED435970-3895-4A14-97BB-18B665D0B6C5Q34306157-692841BC-2CA2-4C5A-B244-ECB26C554551Q34776711-0930C5C8-C18C-411C-AA2F-E7AE5B31134BQ35086172-6C6C3CCF-676E-4B26-B387-5BB91433599BQ36152894-6F9AA730-CAFC-4924-98A1-A9B4C66BE5DBQ36297961-509FF74D-68BB-4973-8290-537E66B1A09AQ36353636-66D35BBF-6D54-4AA9-999F-94B1E9E39C03Q36456015-D3FA2076-52A2-4386-89F9-F5FB215D2B11Q36542196-92E5D10F-9F04-4D46-BE64-EF7821040C7AQ36836435-ECBF99B0-1ED9-4A78-BBC8-4090E2B1F0D4Q37517198-32F22B40-AD91-4BCD-9429-03A7C27269FFQ37727170-11391E7F-9D78-4E4B-9A5D-98D0E3E679E3Q37729882-E159BEE6-9183-46EB-BD38-4420990FC35AQ37873120-D3787BF4-7B24-4EA2-94CF-929B89455AA8Q38789345-403909CB-63C8-4EBD-B98C-79A64100E55AQ38906308-E3E251B2-7824-4DC8-864A-5E0A30B138F1Q39150961-31C5AB0B-A841-4732-82BF-728CC59040BDQ39209784-5E574EB5-8FDC-46B6-A934-9363AF32B295Q39311954-03D640EC-33D4-4D90-AA42-BB82CBC53175Q39363829-3A43A5A1-47BD-4142-93E9-F50A871D090CQ39448483-ADD0AD43-CC0D-45D9-8080-184F9BB7A687Q39653047-6E881C50-CE68-4134-BEB7-9973A7F5A1E3Q39876267-FBC120D3-8251-4C9E-9684-965BB5AF04D8Q40008861-592CFEA0-ED81-4184-8AC1-18F7AD86F0EAQ40338862-A6C4D735-DD8C-46D6-9DB2-2FCD54077DBBQ40591063-E6A844EA-1DFC-44F1-8725-449FCBF94690Q42467533-FE7B1366-B535-4D8E-AACA-209DA6BEE7BF
P50
description
researcher ORCID ID = 0000-0002-4853-8665
@en
wetenschapper
@nl
name
Chia-Ti Tsai
@ast
Chia-Ti Tsai
@en
Chia-Ti Tsai
@es
Chia-Ti Tsai
@nl
type
label
Chia-Ti Tsai
@ast
Chia-Ti Tsai
@en
Chia-Ti Tsai
@es
Chia-Ti Tsai
@nl
prefLabel
Chia-Ti Tsai
@ast
Chia-Ti Tsai
@en
Chia-Ti Tsai
@es
Chia-Ti Tsai
@nl
P106
P1153
7404968014
P31
P496
0000-0002-4853-8665